Business Context and Reporting Period
Company: Supernus Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2017
Reporting Period: Third quarter ended September 30, 2017
This filing serves as a notification that the Company issued a press release regarding its financial results for the third quarter of 2017. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1) but are not explicitly stated within the body of this 8-K filing.
Material Changes
The filing does not list specific material changes or comparative financial data versus the prior period. It solely announces the release of the third-quarter results.
Guidance, Outlook, and Risks
- Conference Call: The Company scheduled a conference call for November 7, 2017, at 9:00 a.m. Eastern Time to present the financial results. A live webcast was available on the Company's website.
- Forward-Looking Statements: The filing contains forward-looking statements regarding plans, strategies, and intentions. These are subject to risks and uncertainties.
- Risk Factors: Investors are directed to Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2016, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2017, for a detailed discussion of risks.
- Legal Disclaimer: Information in Item 2.02 is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2017 revenue, net loss, and cash position figures.
- Verify the Company's cash runway and burn rate as disclosed in the full press release.
- Check the referenced Form 10-K (2016) and Form 10-Q (Q2 2017) for updated risk factors.
- Confirm the date and time of the conference call if seeking management commentary (historical context: Nov 7, 2017).